Australia markets open in 3 hours 59 minutes

BioSyent Inc. (RX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
10.50+0.49 (+4.90%)
At close: 03:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
32,841
31,590
27,925
28,618
22,332
-
Cost of revenue
6,434
5,992
5,067
5,980
4,908
-
Gross profit
26,407
25,598
22,858
22,638
17,424
-
Operating expenses
Research development
133.816
83.271
121.025
160.675
222.361
-
Selling general and administrative
17,416
17,267
15,232
13,657
11,463
-
Total operating expenses
18,234
18,064
15,951
14,390
12,298
-
Operating income or loss
8,173
7,534
6,907
8,248
5,126
-
Interest expense
66.295
68.411
77.142
85.246
92.942
-
Total other income/expenses net
-18.564
-63.114
75.159
78.99
-58.829
-
Income before tax
9,341
8,534
7,431
8,378
5,237
-
Income tax expense
2,288
2,074
1,972
2,097
1,442
-
Income from continuing operations
7,054
6,460
5,458
6,282
3,795
-
Net income
7,054
6,460
5,458
6,282
3,795
-
Net income available to common shareholders
7,054
6,460
5,458
6,282
3,795
-
Basic EPS
0.52
-
0.44
0.49
0.29
0.31
Diluted EPS
0.51
-
0.43
0.49
0.29
0.31
Basic average shares
12,028
-
12,303
12,689
12,977
13,945
Diluted average shares
12,255
-
12,541
12,871
13,094
13,945